173 Epizód

  1. Ep175: Andy Scharenberg on in vivo CAR-T cell therapies

    Közzétéve: 2025. 03. 16.

  2. Ep174: Najat Khan on the TechBio Movement

    Közzétéve: 2025. 03. 03.

  3. Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders

    Közzétéve: 2025. 02. 11.

  4. Ep172: Mostafa Ronaghi on Studying Live Cells at Scale

    Közzétéve: 2025. 01. 27.

  5. Ep171: Ram Aiyar on RNA Editing Medicines

    Közzétéve: 2025. 01. 13.

  6. Ep170: David Schenkein on Investing in the Future of Biotech

    Közzétéve: 2025. 01. 02.

  7. Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

    Közzétéve: 2024. 12. 11.

  8. Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer

    Közzétéve: 2024. 11. 25.

  9. Ep167: Leslie Williams on transfer RNA therapies

    Közzétéve: 2024. 11. 06.

  10. Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity

    Közzétéve: 2024. 10. 15.

  11. Ep165: Zach Hornby on Tackling Cancer Drug Resistance

    Közzétéve: 2024. 09. 26.

  12. Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients

    Közzétéve: 2024. 09. 05.

  13. Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases

    Közzétéve: 2024. 08. 14.

  14. Ep162: Sean McClain on AI for Biologic Drug Discovery

    Közzétéve: 2024. 07. 16.

  15. Ep161: Jeff Stein on a Long-Lasting Flu Drug

    Közzétéve: 2024. 07. 01.

  16. Ep160: Abe Ceesay on Precision Neuroscience

    Közzétéve: 2024. 06. 17.

  17. Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease

    Közzétéve: 2024. 06. 03.

  18. Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery

    Közzétéve: 2024. 05. 20.

  19. Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery

    Közzétéve: 2024. 05. 01.

  20. Ep156: David Liu on New Tools and Techniques for Biology

    Közzétéve: 2024. 04. 16.

1 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Visit the podcast's native language site